Greenlight Biosciences Funding: $277M Raised, Series C
Greenlight Biosciences is based in Medford. It has raised $277M in total funding. Latest round: Series C. Backed by Baird Capital, Jason Dinges, Maveron.
Greenlight Biosciences funding overview
Greenlight Biosciences is based in Medford. Greenlight Biosciences has raised $277M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series C announced in March 2025. The round record for Greenlight Biosciences runs through 2025; nothing later has been disclosed. Investors on record include Baird Capital, Jason Dinges, Maveron, OAK HC/FT, Tsvc Capital, Continental Grain Company and 7 others. 13 distinct backers are named across the disclosed rounds.
Greenlight Biosciences at a glance
Total raised
$277M
Latest round
Series C
Latest round date
March 2025
Headquarters
Medford
Notable investors
Baird Capital, Jason Dinges, Maveron, OAK HC/FT, Tsvc Capital, Continental Grain Company, Cormorant Asset Management, Fall Line Capital
Frequently asked about Greenlight Biosciences funding
How much has Greenlight Biosciences raised?
Greenlight Biosciences has raised $277M in total disclosed funding across the rounds on record.
Who has invested in Greenlight Biosciences?
Baird Capital, Jason Dinges, Maveron, OAK HC/FT, Tsvc Capital, Continental Grain Company are named among the investors backing Greenlight Biosciences.
What was the latest Greenlight Biosciences funding round?
The most recent disclosed round is a Series C, announced in March 2025.
Where is Greenlight Biosciences based?
Greenlight Biosciences is based in Medford.
When did Greenlight Biosciences last raise?
The last disclosed Greenlight Biosciences round closed in March 2025 at Series C.
Round data for Greenlight Biosciences is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Medford and backer lists below.
